Professor Eugenijus Gefenas is a prominent academic at Vilnius University’s Faculty of Medicine, serving as Professor of Medical Ethics and Head of the Department of Medical Ethics. He holds a Doctor of Philosophical Sciences degree from Vilnius University (1993) and has been a key figure in bioethics, research ethics, and global health policy. His roles include Director of Lithuania’s National Bioethics Committee (1995–2018), Vice-President of the European Network of Research Ethics Committees (EUREC), and Chair of UNESCO’s Intergovernmental Bioethics Committee (2015–2017). His research focuses on bioethics, medical ethics, and research ethics, with particular emphasis on international guidelines, clinical trials, and vulnerable populations. He has contributed to shaping global policies, including the 2016 CIOMS International Ethical Guidelines for Health-Related Research. His work spans over 100 publications, emphasizing ethical challenges in biobanking, consent, and healthcare autonomy. Professor Gefenas has coordinated postgraduate research ethics programs and advised international bodies such as the European Commission and the Council of Europe. His advocacy for ethical standards and global health equity underscores his commitment to advancing ethical frameworks in transitional and global healthcare contexts.
Dr. Cynda Hylton Rushton is the Anne and George L. Bunting Professor of Clinical Ethics at the Johns Hopkins Berman Institute of Bioethics and the School of Nursing. She co-chairs the Johns Hopkins Hospital's Ethics Committee and Consultation Service and serves as a Hastings Center Fellow and Trustee Emeritus. As a Fellow of the American Academy of Nursing, she has established herself as an international leader in bioethics and nursing ethics. Dr. Rushton's research focuses on moral resilience, ethical practice, and clinician well-being. She is renowned for developing the Rushton Moral Resilience Scale (RMRS), which has become a standard tool for measuring moral resilience in healthcare professionals. Her work addresses critical issues including moral distress, ethical challenges in clinical practice, and strategies for building resilience in healthcare settings. She co-led the first National Nursing Ethics Summit that produced a Blueprint for 21st Century Nursing Ethics and co-led the State of the Science Initiative: Transforming Moral Distress into Moral Resilience in Nursing. Her recent publications demonstrate a strong focus on moral resilience measurement, pandemic-related ethical challenges, and innovative approaches to ethical practice. The development and validation of the Rushton Moral Resilience Scale-16 represents a significant methodological contribution to the field, while her work on the Mindful Ethical Practice and Resilience Academy (MEPRA) shows practical applications of her theoretical framework. 2023 American Association of Critical-Care Nurses Distinguished Research Lecturer 2020 American Journal of Nursing/Elsevier Book of the Year First Place Award 2019 Sigma Theta Tau International Nurse Researcher Hall of Fame 2014 Fellow, The Hastings Center Multiple Top 100 Women in Maryland recognitions 1990 Fellow, American Academy of Nursing Dr. Rushton serves as chief synergy strategist for Maryland's R3 Resilient Nurses Initiative and co-creator of MEPRA. She has received numerous grants supporting her work on moral resilience and ethical practice, including collaborations with the American Nurses Association and the National Academies of Medicine. She serves on the Nursing Advisory Board for Corporate Counseling Associates and was a member of the National Academies committee that produced the report 'Taking Action Against Clinician Burnout.' She leads the Mindful Ethical Practice and Resilience Academy (MEPRA) and serves as chief synergy strategist for Maryland's R3 Resilient Nurses Initiative, a statewide program building resilience in nursing students and novice nurses. Her work bridges academic research with practical implementation in clinical settings, creating sustainable frameworks for ethical practice.
Dr. Arti Singh is a Senior Lecturer in the Department of Epidemiology and Biostatistics at the School of Public Health, Kwame Nkrumah University of Science and Technology (KNUST) in Kumasi, Ghana. She is an enthusiastic researcher, academician, and clinician with expertise in epidemiology and global health issues, particularly focused on non-communicable diseases and tobacco control in the Ghanaian context. Dr. Singh's primary research interests include: Non-communicable diseases epidemiology and management Tobacco control policy and implementation Community engagement and community-based participatory research Genomic research related to stroke and other conditions Public health policy development and evaluation Her recent publication record demonstrates a strong focus on tobacco control research in Ghana, with multiple studies examining tobacco taxation policies, smoke-free legislation implementation, and the illicit cigarette market. She has also conducted significant research on non-communicable diseases among people living with HIV, stroke outcomes in Ghanaian populations, and mobile health interventions for hypertension management. Her work often employs mixed methods approaches and emphasizes stakeholder engagement throughout the research process, with particular attention to community-based participatory research methodologies. Dr. Singh appears to be actively involved in several major research initiatives including the Stroke Investigative Research and Education Network (SIREN) and has contributed to studies examining the ethical, legal, and social implications of genomic research in Africa. Her research has been published in high-impact journals including BMJ Global Health (impact factor 8.1), BMJ Open, and various neuroscience and public health publications. As a Senior Lecturer at KNUST's School of Public Health, Dr. Singh contributes to academic training in epidemiology and biostatistics. Her work demonstrates a commitment to generating evidence that directly informs public health policy and practice in Ghana and across sub-Saharan Africa, with particular emphasis on translating research findings into actionable policy recommendations.
Dr. Arnold Sauter serves as Deputy Head of the Office for Technology Assessment at the German Bundestag (TAB), a position he has held since 2012. He is affiliated with the Institute for Technology Assessment and Systems Analysis (ITAS) at Karlsruhe Institute of Technology, where he contributes to research on biotechnology, genetic engineering, and technology assessment. With a background in biology and zoology, Dr. Sauter has been instrumental in shaping policy advice for the German parliament on emerging technologies and their societal implications. Dr. Sauter's research interests focus on the assessment of biotechnologies, particularly genetic engineering, genome editing, and their ethical, environmental, and societal implications. His work examines how emerging technologies like gene drives, bacteriophages, and crisis prediction systems impact society, requiring careful consideration of risks, benefits, and regulatory frameworks. He investigates the intersection of science, policy, and society, emphasizing the importance of responsible innovation and evidence-based decision-making in complex technological landscapes. Analysis of Dr. Sauter's recent publications reveals a strong focus on emerging biotechnologies and their societal implications. His work spans genetic engineering applications, crisis management systems, and the assessment of novel biological technologies. The research demonstrates interdisciplinary approaches that integrate scientific, ethical, and policy perspectives to address complex challenges in technology governance. His publications consistently emphasize the need for anticipatory governance and stakeholder engagement in managing technological risks and opportunities. Active contributor to parliamentary technology assessment since 1995 Key advisor on biotechnology and genetic engineering policy Regular collaborator with international technology assessment networks Contributor to European-level discussions on science policy Dr. Sauter leads and participates in numerous research projects advising the German Bundestag on emerging technologies. His work involves coordinating interdisciplinary teams to assess the implications of new scientific developments for policy. He has established strong connections between academic research and parliamentary decision-making, facilitating knowledge transfer from scientific communities to policy contexts. His leadership in the TAB office has strengthened Germany's capacity for evidence-based technology governance. As Deputy Head of TAB, Dr. Sauter oversees research teams focused on technology assessment across various domains including biotechnology, environmental science, and health technologies. His leadership guides the organization's approach to analyzing emerging technologies and their societal implications, ensuring comprehensive assessments that inform parliamentary decision-making on complex scientific issues.
Dr Kate Greasley serves as an Associate Professor in Law at the University of Oxford and Tutorial Fellow at Hertford College. She teaches undergraduate courses in Criminal Law, Jurisprudence, and Medical Law & Ethics, building on her distinguished academic background including a first-class law degree from New College, Oxford. Her educational qualifications: First-class Law Degree, New College, Oxford BCL, University of Oxford DPhil, University of Oxford (Thesis: Personhood in Abortion Laws) Dr Greasley's research critically engages with Philosophy of Law , Criminal Law Theory , Applied Ethics , and Feminist Legal Theory , particularly focusing on medical law controversies. Her influential publications include the monograph Arguments About Abortion: Personhood, Morality, and Law (2017) and co-authored work Abortion Rights: For and Against (2017), establishing her as a leading voice in abortion jurisprudence. Analysis of her recent publications reveals consistent scholarly engagement with the moral foundations of legal rules in high-stakes contexts, especially reproductive rights and end-of-life decisions. Her work demonstrates interdisciplinary rigor bridging legal doctrine, philosophical ethics, and practical medical regulation, with recurring emphasis on personhood concepts and bodily autonomy. Dr Greasley's scientific awards have not been detailed in available institutional records. As Hertford College's Tutorial Fellow, she provides comprehensive academic supervision for undergraduate law students. Her professional trajectory includes a stipendiary lectureship at Hertford College during doctoral studies, a Junior Research Fellowship at University College, Oxford, and prior lecturing position at University College London's Law Faculty before returning to Hertford in 2018.
Mark Stoltenberg, MD, MPH, MA serves as an Assistant Professor at Harvard Medical School with primary affiliations at Massachusetts General Hospital (MGH) and Mass General Brigham (MGB). He is a faculty member in the Division of Palliative Care and Geriatrics at MGH, focusing on global health equity and innovative care models for vulnerable populations worldwide. His educational journey includes: Undergraduate degree in Religion from Duke University Medical degree and Master's in Bioethics and Health Policy from Loyola University Chicago Family Medicine Residency at Northwestern University Palliative Care Fellowship at Harvard University Global Health Fellowship at MGH MPH from Harvard T.H. Chan School of Public Health Dr. Stoltenberg's research centers on collaborative responses to suffering across diverse global contexts, with extensive fieldwork in Latin America, Africa, and the Caribbean. His work emphasizes capacity building through longitudinal partnerships with palliative care leaders in Belize, Chile, Colombia, Jamaica, Kenya, and Rwanda. As a founding member of the Global Palliative Education Consortium (GPEC) and palliative care advisor to the Pan American Health Organization (PAHO), he drives systemic change in underserved regions through education program development and leadership mentorship. His approach integrates cultural humility and structural competency to address health disparities at their roots. Analysis of his 2021-2025 publications reveals three dominant research trajectories: (1) Development of context-specific palliative care training programs across Latin America and Africa, (2) Innovative communication frameworks for high-mistrust settings (particularly during COVID-19), and (3) Integration of palliative care into emergency departments and critical care units. His work consistently prioritizes local leadership development over external intervention, with methodologies emphasizing participatory design and sustainable implementation. Dr. Stoltenberg maintains active longitudinal partnerships across six countries to mentor emerging palliative care leaders and co-develop education programs. His work with GPEC trains US-based specialists for global engagement while simultaneously building in-country capacity through virtual communities like Project ECHO in the Caribbean. Though specific grant details aren't documented here, his research demonstrates consistent funding for cross-border implementation science and curriculum development. He operates within MGH's Global Palliative Care Program and co-founded the Global Palliative Education Consortium, establishing virtual learning networks that connect US trainees with global practitioners. His current initiatives focus on scaling communication frameworks tested in Brazilian ICUs and expanding the advanced diploma program for palliative care leaders across Latin America.
Julie S. Armin is an Assistant Professor in the Department of Family and Community Medicine at the University of Arizona College of Medicine – Tucson, with a secondary appointment as Assistant Professor of Practice in Health Promotion Sciences. She also serves as the Director of the Health Disparities Curriculum for the College of Medicine. As a medical anthropologist with a PhD from the University of Arizona (2015), Dr. Armin focuses on improving healthcare access and reducing health disparities for historically marginalized populations through community-based methodologies. Dr. Armin's educational background includes: PhD in Anthropology (Sociocultural/Medical) from the University of Arizona (2015) MA in Anthropology from San Francisco State University (2006) Her research program centers on addressing gaps in cancer prevention and treatment for populations marginalized due to race, social class, immigration status, and disability. Dr. Armin employs qualitative, multi-method, and community-based approaches to examine how cancer care is affected by structural factors and to develop interventions that improve access to care. Her current work emphasizes advance care planning among English and Spanish-speaking people living with cancer and their providers, and access to cancer care for people with disabilities. Dr. Armin's recent publications demonstrate a strong focus on health disparities, particularly at the intersection of disability and race/ethnicity in cancer care. Her work frequently addresses the experiences of Native American women with intellectual and developmental disabilities, barriers to cervical cancer screening, and the development of culturally adapted interventions. She has published extensively in medical anthropology, oncology, and public health journals, with recent work examining AI in cancer control through a justice, equity, diversity, and inclusion lens. Among her professional achievements: University of Arizona Cancer Center Full Membership (Fall 2024) Building Research Capacity Fellowship ADFM (Fall 2023) Dr. Armin is actively involved in several significant research projects including "Improving Shared Decision-Making about Cancer Screening Among American Indian Women Experiencing Intellectual Disabilities" (as co-PI), and "Improving Advance Care Planning through Better Care Coordination" funded by the American Academy of Family Physicians. She also serves as a Co-Investigator on projects addressing tobacco cessation interventions and expanding patient-centered cancer care for underserved populations in Southern Arizona. Her teaching portfolio includes courses on health disparities, histories of health inequity, disability perspectives, and directed research experiences focusing on cancer care for marginalized populations. Dr. Armin is committed to integrating structural competence into medical education and training future healthcare providers to address health inequities.
Luk Rombauts is an Adjunct Clinical Professor in the Department of Obstetrics and Gynaecology at Monash University and a Research Fellow at the Hudson Institute. He serves as the Group Medical Director of Monash IVF Group and holds a prominent role in national and international reproductive medicine organizations. His academic and clinical work is deeply embedded in women’s health, with a focus on infertility, endometriosis, and reproductive surgery. His educational and professional training, though not explicitly detailed, is evident through his leadership roles, editorial positions, and subspecialty certification oversight via RANZCOG. He has played a key role in shaping clinical standards and training in reproductive endocrinology and infertility. Rombauts’ research interests center on endometriosis and embryo implantation, with strong emphasis on clinical and translational research. His work spans molecular mechanisms of implantation, biomarker discovery, AI applications in gynaecology, and long-term health outcomes of fertility treatments. He actively contributes to advancing evidence-based care through national guideline development and digital health implementation. His recent publications reflect a multidisciplinary approach, integrating molecular biology, epidemiology, bioethics, and health policy. Themes include miRNA regulation in endometrial receptivity, cardiovascular risks in ART patients, commercialization of fertility services, and innovative diagnostic tools using AI. These works demonstrate a consistent focus on improving patient outcomes and health system responsiveness. Past President, Fertility Society of Australia and New Zealand Past President, World Endometriosis Society Trustee, World Endometriosis Research Foundation Scientific Chair, 2008 World Congress on Endometriosis Scientific Chair, 2012 World Congress of Human Reproduction Associate Editor, Human Reproduction Member, RANZCOG Grants and Scholarship Committee Rombauts is actively involved in mentoring and training future specialists, serving as a supervisor and examiner for the Certificate of Reproductive Endocrinology and Infertility. He leads and collaborates on major research grants, including projects on mitochondrial donation (MitoHOPE), AI in endometriosis (EndoAIMM), and digital health optimization. He is a chief investigator on multiple national and international collaborative studies, reflecting his leadership in large-scale, interdisciplinary research initiatives. He is affiliated with key research networks including the Hudson Institute, Monash IVF Group, and the Australian Endometriosis Clinicians Collaborative (AECC), contributing to a robust ecosystem of clinical innovation and research translation in reproductive medicine.
George Tomossy is a Senior Lecturer at Macquarie Law School, specializing in health law, research ethics, and sustainable development. He holds dual roles as a legal academic and a practicing barrister/solicitor in Ontario, Canada. His research focuses on global health governance, legal frameworks for public health, and capacity-building initiatives in developing countries like Bangladesh and Indonesia. Tomossy has led numerous institutional roles, including Director of Learning and Teaching at Macquarie Law School (2011–2015) and membership in Academic Senate committees. He received the 2014 Vice-Chancellor’s Award for Programs Enhancing Learning, recognizing his contributions to pedagogical innovation. His research interests span ethical challenges in biomedical innovation, legal governance of public health crises (e.g., pandemic responses), and the intersection of human rights with healthcare access. He has co-edited influential books on topics like global health and human experimentation, and his work appears in journals such as the Journal of Law and Medicine and Journal of Bioethical Inquiry . Key projects include capacity-building programs in Bangladesh and Indonesia, addressing trade regulations, environmental sustainability, and public health policy. His recent publications address issues like mental capacity assessments during emergencies and the legal complexities of brain death and pregnancy. Tomossy’s advising includes notable completions like A. Guida’s thesis on GMO regulations and L. Barry’s study on client decision-making capacity. His work bridges legal scholarship with practical solutions for global health challenges.
Deepika Yadav is a Research Fellow at Stockholm University's Department of Computer and Systems Sciences (DSV), affiliated with the Stockholm Technology & Interaction Research (STIR) group. She leads the Digital Futures Postdoc Fellowship project 'Relational Aspects of Care in Intimate Digital Health Technologies' (2021–2023), focusing on designing technologies to address gaps in women’s healthcare. Her research bridges Human-Computer Interaction (HCI) and global development, emphasizing underrepresented groups and resource-constrained settings. Her work explores sociotechnical challenges in digital health technologies, particularly around intimate care such as fertility tracking, lactation support, and workplace health infrastructure. She employs innovative methods like Soma Design to enhance somatic literacy and co-design inclusive solutions. Collaborations span academic institutions including KTH Royal Institute of Technology and RISE Research Institutes of Sweden through the Digital Futures initiative. Key themes include trust in algorithmic health services, interpersonal care dynamics, and workplace adaptations for bodily needs. Her projects emphasize participatory design with marginalized communities, aiming to improve healthcare access and equity through technology. Recent publications focus on digital contraception, gig-worker health, and maternal support systems in India. Deepika’s research contributes to both academic discourse and practical innovations, fostering ethical tech development that prioritizes human well-being and societal impact. She has advised on collaborative learning platforms for community health workers and pioneered mobile health solutions in rural India.
Anna Bonmatí-Tomàs is an Associate Professor in the Department of Nursing at the University of Girona (UdG), where she has been a faculty member since 2019. She is a core member of the Health and Healthcare Research Group and plays a key leadership role as Coordinator of the European Training Consortium for Public Health and Health Promotion (ETC-PHHP) since 2016. She also serves on the Florence Network Board and is Associate Editor of Global Health Promotion . Her work bridges nursing, public health, and health promotion with a strong focus on equity and social inclusion. Bachelor in Pharmacy – University of Barcelona (1996) Diploma in Nursing – University of Girona (2009) Doctorate – University of Girona (2016) Multiple Master’s degrees in Nutrition, Community Pharmaceutical Care, Health Promotion, Bioethics, and Health Management Her research interests are centered on public health, health promotion, salutogenesis, health equity, migrant and women’s health, nursing education, and digital health interventions . She applies qualitative, quantitative, and mixed-methods approaches to explore health behaviors, system challenges, and educational outcomes. Her work often targets vulnerable populations, including immigrants and socially excluded women, aiming to build resilience and reduce health disparities. The 15 most recent publications reflect a consistent trajectory in nursing and public health research, with strong emphasis on health promotion, continuity of care, nursing education, medication safety, and mental wellbeing of healthcare professionals . The articles span high-impact journals such as BMC Health Services Research , Nurse Education Today , and Global Health , demonstrating methodological diversity and international collaboration. Key themes include the development of assessment tools, evaluation of training interventions, and qualitative exploration of social determinants of health. She has received recognition including a 2018 grant for research dissemination and social commitment. Her scientific contributions are further acknowledged through leadership roles in editorial and academic networks. Grants for initiatives and activities in the areas of research dissemination and social commitment (2018) Anna Bonmatí-Tomàs has led and participated in multiple research projects funded by the Institute of Health Carlos III and the European Commission. These include studies on health literacy during the pandemic, cardiovascular risks in sexual and gender minorities, and empowerment of women at risk of exclusion. She mentors students and collaborates with a multidisciplinary team at UdG. She has conducted research stays in Germany, Croatia, the Netherlands, France, and the UK, enhancing her transnational academic profile. She is actively involved in developing educational materials and assessment tools, such as the Medicorrect scale and simulation-based learning frameworks. Her work in the Chair on Health Promotion at UdG supports capacity building in salutogenic approaches across Europe.
Nicole L. Achee is a Research Professor in the Department of Biological Sciences and holds a joint Associate Professor appointment in the Eck Institute for Global Health at the University of Notre Dame. She is a leading medical entomologist with over 20 years of experience in vector-borne disease research, focusing on mosquito behavior, vector ecology, and the development and evaluation of vector control tools such as spatial repellents. Her work spans multiple countries including Belize, Indonesia, Peru, Thailand, and Zambia, with major collaborations funded by the Bill & Melinda Gates Foundation, Unitaid, and the U.S. Department of Defense. Education: Ph.D. in Medical Entomology, Uniformed Services University of the Health Sciences (USUHS), 1999–2004 M.Sc. in Zoology, Texas A&M University, 1992–1995 B.S. in Biology, St. Louis University, 1988–1992 Her research interests include infectious and vector-borne diseases, public health product evaluation, vector ecology, intervention trials, and global health policy. She has pioneered the use of spatial repellents in large-scale clinical trials to reduce human-vector contact for dengue and malaria prevention. Her work integrates laboratory and field studies with GIS and remote sensing for disease risk modeling. The 15 most recent articles reflect a strong focus on spatial repellents, mosquito behavior, vector control efficacy, and public health implementation. The research spans disciplines such as entomology, epidemiology, public health, and computational modeling, with sub-fields including insecticide resistance, oviposition behavior, push-pull strategies, and community-level intervention impacts. Scientific Awards and Leadership: Lead Principal Investigator, REDI-NET (CDMRP) Scientific Director, Unitaid-funded spatial repellent trials Member, WHO Vector Control Advisory Group (VCAG) Past-Chair, American Committee of Medical Entomology (ACME), ASTMH Lead Scientist, WHO Guidelines for Efficacy Testing of Spatial Repellents Partner, Worldwide Insecticide Resistance Network (WIN) Nicole Achee has advised numerous Master of Science in Global Health students at Notre Dame and co-directs the Belize Vector and Ecology Center (BVEC), a hub for research, training, and education in public health. She has secured major grants from the Gates Foundation, SC Johnson, and CDMRP, supporting long-term field trials and capacity building in endemic regions. Her work directly informs WHO public health policy and advances global strategies for vector-borne disease control. Labs and Teams: The Achee/Grieco Lab at Notre Dame conducts multidisciplinary field and laboratory research on vector behavior and control. The lab collaborates internationally and mentors undergraduate and graduate students, emphasizing hands-on training in global health research.
Mathieu Feagan is an Adjunct Assistant Professor at the University of Waterloo, affiliated with the School of Environment, Resources and Sustainability and cross-appointed to the Department of Geography and Environmental Management and the School of Environment, Enterprise and Development. His work bridges social theory, Indigenous epistemologies, and transdisciplinary approaches to urban resilience and environmental justice. PhD , Communication and Culture, Ryerson and York Universities (2015) MA , Canadian and Native Studies, Trent University (2007) BA , Anthropology, McGill University (2000) His research explores emancipatory pedagogies , ecological consciousness , and nature-based solutions for urban resilience, with a focus on Indigenous knowledge systems and equitable co-production of knowledge . He leads and collaborates on grants such as the New Frontiers in Research Fund exploration grant and National Science Foundation RULA IRES projects, emphasizing decolonial frameworks and transdisciplinary learning . Recent publications highlight co-producing knowledge systems for coastal cities, critical pedagogical designs for sustainability, and political ecology of health in extractive industries. His work integrates feminist theory , data visualization , and ecohealth methodologies to address climate justice and urban governance. Scientific Awards & Grants 2024: New Frontiers in Research Fund exploration grant ($250,000 CDN) 2023: Waterloo Climate Institute Seed Grant ($15,000) 2022: LITE Seed Grant ($2,600) 2022: NATURA Student Research Award ($2,500) 2021: Ecological Society of America Science Communication Award Feagan contributes to ecohealth communities of practice and teaches courses including Climate Justice , Action Research , and Urban Futures Project .
Anetta Jedličková serves as a Lecturer at the Department of Philosophy, Faculty of Humanities, Charles University in Prague, and concurrently teaches Ethics at the Faculty of Biomedical Engineering, Czech Technical University. She chairs the Committee for Ethical Research at FHS UK and supervises doctoral candidates in Applied Ethics. Her academic foundation includes: Doctor of Medicine, Charles University Faculty of Medicine (1985-1991) Postgraduate Pharmaceutical Medicine, University of Wales Cardiff (1999-2000) PhD in Applied Ethics, Charles University Faculty of Humanities (2011-2014) Dr. Jedličková's research integrates clinical medicine with ethical frameworks, focusing on AI ethics, pharmacovigilance, and risk management in clinical research. Her extensive training in clinical trial auditing and AI ethics certification positions her at the intersection of medical practice and emerging technology governance. Analysis of her 2022-2024 publications reveals dominant trends in AI ethics (40% of output), clinical research ethics (30%), and medical specialty ethics (30%). Her work consistently addresses ethical implementation challenges in autonomous systems, pandemic-responsive clinical protocols, and cross-disciplinary medical applications. She actively mentors doctoral students in Applied Ethics and secures research funding through Technology Agency of the Czech Republic (CZDEMOS4AI) and Czech Ministry of Interior grants for crisis distribution systems. Her IEEE AI Ethics Oversight membership demonstrates international recognition in technology governance. Dr. Jedličková leads the FHS UK Committee for Ethical Research while contributing to the IEEE AI Ethics Oversight Working Group, establishing dual institutional frameworks for ethical review in academic research and AI development.
Brenda M. Schiltz, M.D., M.A., is Associate Professor of Pediatrics at Mayo Clinic College of Medicine and Science, triple-board-certified in Pediatrics, Pediatric Critical Care, and Hospice & Palliative Medicine. She practices in the Departments of Pediatric & Adolescent Medicine and Critical Care, serves as Chair of the Pediatric Ethics Advisory Group, and holds multiple safety and educational leadership roles at Mayo Clinic Rochester. Education & Training: 2004 MD – Rosalind Franklin University of Medicine & Science / Chicago Medical School 2000 MS Applied Physiology – Rosalind Franklin University 1999 BS Biology & Chemistry – University of Wisconsin–Milwaukee 2005–2010 Post-graduate clinical training (internship, residency, fellowship) – Medical College of Wisconsin & Affiliated Hospitals 2010 MA Bioethics – Medical College of Wisconsin Research & Scholarly Focus: Dr. Schiltz’s scholarly work integrates pediatric critical care , palliative medicine , and clinical ethics . She investigates consultation patterns, resource stewardship, end-of-life decision making, and cross-cultural care for seriously ill children. Additional interests include quality-improvement methodologies, medical professionalism education, and global pediatric critical-care capacity building. Her peer-reviewed output spans prospective cohort studies, mixed-methods global-health projects, systematic reviews, and quality-improvement reports, with a clear trend toward embedding palliative principles into high-technology PICU environments and optimizing health-system processes to reduce non-beneficial treatment and shorten length of stay. Honors & Awards: 2024 Founders Award, Children’s HeartLink 2020 Top Doctor, Minnesota Monthly Multiple Favorite Faculty Awards, Mayo Clinic Rochester (2018, 2019) Society of Critical Care Medicine Family-Centered Care Innovation Award (2013) Gold Humanism in Medicine Charter Member & Dean’s Award, RFUMS (2004) Leadership & Service: Dr. Schiltz chairs the Pediatric Ethics Advisory Group, serves as Associate Patient Safety Officer for the Children’s Center, sits on the Minnesota Medical Association’s Committee on Ethical & Legal Affairs, and represents Mayo Clinic in state POLST and palliative-care coalitions. She has directed the Pediatric Critical Care Fellowship program and continues to mentor residents and fellows through the Clinical Competency Committee. She is active in the Society of Critical Care Medicine, American Academy of Hospice & Palliative Medicine (Fellow), American Society for Bioethics & Humanities, and multiple Mayo institutional committees ranging from trauma performance improvement to integrative medicine.
